Overview
Cardiex Restricted (ASX:CDX) is an ASX-listed medical expertise firm leveraging its proprietary SphygmoCor® expertise to develop and market vascular biomarker applied sciences and digital options targeted on the world’s largest well being issues. The corporate’s groundbreaking expertise – SphygmoCor® – set the benchmark for noninvasive measurement of central aortic pressures and associated arterial well being traits, collectively known as vascular biomarkers.
Whereas measuring arterial well being parameters had all the time been thought of clinically useful, it was not thought of for routine out-patient scientific use because it beforehand required an invasive catheterization process with a strain sensor inserted into the aorta. Based on 40 years of hemodynamics research and backed by 20+ years of analysis, Cardiex’s SphygmoCor expertise employs non-invasive methods to evaluate “central aortic waveforms,” providing worthwhile insights into varied clinically important arterial well being parameters together with arterial stiffness, central blood strain (the strain on the coronary heart), pulse strain, and essential indicators of vascular well being for main organs equivalent to the guts, mind and kidneys.
Assessing central blood strain instantly on the coronary heart is deemed superior to traditional blood strain measurements taken on the arm, primarily owing to the guts’s proximity to very important organs. Cardiex’s FDA-cleared units exchange conventional blood strain expertise for first-line screening and monitoring of arterial well being standing. The distinctive physiologic insights from the corporate’s units present clinically related info that helps information therapy selections and supply profound advantages for all members of the healthcare group:
For Healthcare Suppliers: Allow physicians to make extra knowledgeable therapy selections primarily based on clinically related vascular well being information.
For Sufferers: Give sufferers the instruments to make higher selections about their very own well being.
For Pharmaceutical Corporations: Generate dependable, real-world, clinically related information to speed up drug improvement and commercialization.
For greater than 20 years, the corporate’s SphygmoCor expertise has set the benchmark for vascular biomarker assessments, adopted by premier hospitals and pharmaceutical giants worldwide. SphygmoCor is the chosen expertise for measuring central blood strain in all the “prime 20 hospitals” within the US and has performed a vital function within the scientific trials of main companies together with Bayer, AstraZeneca, Roche, Novartis and GlaxoSmithKline.
Between 2002 and 2023, CDX obtained 5 FDA clearances, the most recent for the CONNEQT Pulse, a first-of-its-kind related vascular biometrics monitor.
Cardiex units have beforehand been offered and used completely in scientific settings – principally by specialist clinicians, for analysis, and by pharmaceutical firms for drug evaluation. The introduction of CONNEQT Pulse represents a big shift for Cardiex, permitting the corporate to enter the related care market and transition from area of interest segments to the mass healthcare market. Priced comparably to a house well being monitor, the CONNEQT Pulse is positioned for widespread adoption and might be deployed at scale normally healthcare practices, properties, or any location the place sufferers are current.
The CONNEQT Pulse may even bolster Cardiex’s portfolio in scientific trial options with the introduction of a decentralized scientific trial (DCT) platform. The Cardiex DCT platform empowers scientific trial managers to remotely monitor hundreds of sufferers of their properties, enabling pharmaceutical firms to extra successfully consider potential vascular outcomes throughout varied trial phases. This results in elevated effectivity and cost-effectiveness in trial outcomes.
Moreover, in response to the rising demand for proactive well being monitoring, Cardiex shall be launching an revolutionary wrist-worn gadget that leverages the SphygmoCor expertise to ship a medical grade wearable with capabilities far past standard well being trackers. The CONNEQT Band shall be a wearable “cuffless” gadget designed to watch vascular well being in sufferers in addition to to supply normal well being insights to customers.
Cardiex’s purpose is to determine a holistic ecosystem that promotes cardiovascular well-being and empowers customers to proactively handle their well being as an integral a part of people’ well being routines, contributing to a paradigm shift in preventive cardiovascular care.
The corporate’s first-mover benefit and unique expertise FDA-cleared for noninvasive measurement of central pulse pressures and vascular biomarkers throughout all grownup demographics grant it a particular market place. CDX just lately secured AU$14 million in funding, which is sufficient to steer the corporate in the direction of profitability.
With the entry into the related care house market with the CONNEQT Pulse, CDX is transitioning in the direction of a recurring income mannequin primarily based on month-to-month subscription charges. This could excite traders, provided that the recurring income mannequin will obtain a better a number of by the market, thereby boosting the corporate’s valuation.
Firm Highlights
- Cardiex Restricted is an ASX-listed medical expertise firm that develops and markets vascular biomarker applied sciences and digital options for the world’s largest well being issues.
- The corporate’s choices embody FDA-cleared medical and residential well being units alongside digital options tailor-made for managing well being and wellness, delivering distinctive physiologic insights that inform scientific therapy selections.
- The corporate’s groundbreaking expertise – named SphygmoCor® – set the benchmark for measuring central aortic pressures and associated arterial well being traits, collectively known as vascular biomarkers.
- These biomarkers, extensively researched and detailed in quite a few peer-reviewed journals, assess cardiovascular threat and information illness administration by predicting organ harm (equivalent to the guts, mind, and kidneys) and outcomes (together with coronary heart failure, ischemic coronary heart illness, and stroke), considerably influencing illness prognosis and scientific therapy.
- CDX obtained 5 FDA clearances from 2002 to 2023, the latest for the CONNEQT Pulse, a world-first related vascular biometric monitor. The CONNEQT Pulse targets new and important healthcare channels and transitions the corporate in the direction of a recurring income mannequin primarily based on month-to-month subscription charges.
- CDX’s expertise is uniquely FDA-cleared for noninvasive measurement of central pulse pressures and vascular biomarkers throughout all grownup demographics – thereby granting it a particular aggressive market place. With a big funding spherical just lately secured, CDX is poised for profitability forward.
Merchandise and Manufacturers
The corporate’s resolution is organised underneath two manufacturers: ATCOR and CONNEQT.
ATCOR
ATCOR gives options for hospitals, analysis and pharma, and specialist clinician markets. ATCOR’s options have been utilized in 46 pharmaceutical scientific trials so far, throughout greater than 1,700 research websites worldwide, and have been highlighted in over 2,400 peer-reviewed research showcased in top-tier medical journals. It gives two units – the corporate’s flagship gadget, the SphygmoCor XCEL, and the SunTech Oscar 2 with “SphygmoCor Inside”.
SphygmoCor XCEL: The SphygmoCor XCEL measures central and brachial blood pressures, offering insights into cardiovascular perform. Moreover, it assesses quite a few different clinically related vascular biomarkers, providing a complete understanding of arterial stiffness and well being. These superior physiological measurements allow early detection of potential cardiovascular points, guiding focused interventions for sustaining or bettering total cardiovascular well being.
SunTech Oscar 2 with “SphygmoCor Inside”: Collectively developed and marketed by SunTech Medical and Cardiex, the Oscar 2™ ABPM with “SphygmoCor Inside” produces a set of distinctive vascular well being options and well being insights captured by the SphygmoCor expertise over a steady interval. It gives worthwhile diagnostic info that conventional ambulatory blood strain screens are incapable of measuring.
CONNEQT
CONNEQT is concentrated on units and options for house well being, distant affected person monitoring, and decentralized scientific trials. Cardiex gives two units underneath the CONNEQT model – the just lately FDA-cleared CONNEQT Pulse and the upcoming CONNEQT Band wearable. The corporate estimates CONNEQT’s complete addressable market alternative to be almost $283 billion throughout three markets – distant affected person monitoring ($175 billion), well being wearables ($104 billion), and decentralized scientific trials ($14 billion).
CONNEQT Pulse: The CONNEQT Pulse gives measurements of each central and brachial blood pressures, alongside vascular biomarkers reflecting arterial stiffness and total vascular well being—metrics as soon as completely solely out there to specialist clinics, analysis, and pharmaceutical firms. As a Bluetooth-enabled gadget, it empowers sufferers and well being fanatics to trace their arterial well being from house, using the identical superior instruments utilized by prime cardiologists in analysis facilities and clinics.
Physicians can prescribe the CONNEQT Pulse to sufferers requiring coronary heart well being monitoring. Affected person information seamlessly integrates with the CONNEQT Affected person Administration Portal (CPMP), a HIPAA-compliant cloud-based software that allows healthcare suppliers to remotely monitor sufferers’ arterial well being by means of a pill. Moreover, customers and sufferers can entry complete arterial well being insights, teaching, life-style packages, and extra well being sources by way of the CONNEQT app.
CONNEQT Band: CONNEQT Band is a world’s-first twin sensor arterial well being wearable gadget that includes an revolutionary design with twin (wrist-and finger-based) photoplethysmography (PPG) optical sensors. The wrist-based sensor constantly captures physiological information equivalent to coronary heart fee, respiration, stress, exercise, sleep, and pulse oximetry, whereas our patented on-demand finger-based aspect sensor uniquely derives clinically significant vascular biomarkers representing arterial stiffness and cardiovascular well being.
By combining information from each sensors, the CONNEQT Band gives customers a complete view of their total cardiovascular well being which has by no means been out there outdoors of a doctor’s workplace. The CONNEQT Band can also be supported by the CONNEQT app, out there for each iOS and Android units, which serves as a hub the place customers can simply entry detailed experiences, monitor their progress over time, discover content material, and obtain customized well being insights and suggestions.
The CONNEQT Band is at the moment within the technique of FDA submission preparation. This revolutionary gadget is poised to increase the corporate’s portfolio in related well being expertise, providing customers a brand new, user-friendly software for monitoring their well being metrics. With its cutting-edge options, the CONNEQT Band is anticipated to make a big influence in the way in which people handle their wellness, bridging the hole between superior well being monitoring and on a regular basis comfort.
A major world market alternative in wearable well being units is pushed by almost 1.3 billion hypertensive and different vascular illness sufferers. A few of the different wearable gadget companies have attracted important funding at excessive valuations in latest occasions. For example, Oura Well being, a Finnish firm that makes good rings for monitoring sleep and bodily exercise, was valued at $2.55 billion in April 2022.
Board of Administrators & Administration
Craig Cooper – Chief Govt Officer and Govt Director
Craig Cooper has established quite a few affluent well being, digital media, expertise and wellness ventures. Notably, he co-founded Increase Cell, a distinguished telecommunications firm acknowledged as one of many main cell phone companies within the USA. He’s acknowledged as a distinguished authority and influential determine on a world scale in cellular and wi-fi expertise, in addition to companies associated to digital well being and medical expertise. His enterprise capital endeavors have secured over AU$3 billion, financing a number of the most impactful world digital media expertise firms. Cooper can also be a principal of C2 Ventures, Cardiex’s largest shareholder.
Niall Cairns – Govt Chairman
Niall Cairns boasts a profitable 25-year document of investing in each non-public and public firms. He has performed a pivotal function in advancing the worldwide growth of greater than 50 enterprises spanning varied sectors, together with digital media, agtech, medtech, client web, and SaaS-based companies. Cairns can also be a principal of C2 Ventures, Cardiex’s largest shareholder.
King Nelson – Non-executive Director
King Nelson brings over 30 years of intensive expertise in medical units. He was beforehand the president and CEO at Uptake Medical Company, concentrating on therapies for emphysema and lung most cancers. Earlier than Uptake, he served as president and CEO of Kerberos Proximal Options, an organization later acquired by FoxHollow Applied sciences. He was additionally president and CEO of VenPro, a coronary heart valve enterprise acquired by Medtronic. King additionally accrued 19 years of expertise with Baxter Worldwide and American Hospital Provide Company, progressing by varied roles with rising duties. These roles included serving as division president for Dade Diagnostics, Bentley Labs, and Baxter’s Perfusion Providers. Nelson is at the moment the CEO at Q’Apel Medical, a medical gadget firm specializing in neurovascular illness.
Charlie Taylor – Non-executive Director
Charlie Taylor has over three many years of worldwide advisory expertise and just lately concluded his tenure as senior companion at McKinsey, the place he oversaw the well being and public sector apply. Taylor has recommended quite a few non-public and public sector healthcare organizations in Australia and globally, overlaying areas equivalent to technique, digitalization, operational enhancements, progress transformations, worldwide growth, provide chain administration, mergers and acquisitions, and board governance. He’s a non-executive director of Healius, a number one Australian well being diagnostics firm, and a part-time senior board advisor at McKinsey for the well being and public sector apply.
Sanjeev Bhavnani, M.D. – Chief Scientific Officer
Dr. Sanjeev Bhavnani has served as a senior medical officer on the Digital Well being Middle of Excellence throughout the FDA’s Middle for Gadgets and Radiological Well being (CDRH), overseeing scientific and scientific initiatives regarding digital well being and medical units incorporating synthetic intelligence.
Bhavnani can also be at the moment a senior heart specialist and principal investigator of digital well being and machine studying at Scripps Clinic in San Diego, California, the place he leads packages to develop and validate new applied sciences and to guage the protection and effectiveness of DHTs, nanosensors, cloud-based analytical platforms, handheld imaging applied sciences, AI/ML algorithms and software program as a medical gadget. For over a decade, Bhavnani was the principal investigator of 90 scientific trials and affected person care packages. These packages have enrolled over 30,000 sufferers within the US and in resource-limited areas. His workforce developed the SMART-FHIR integration interface for DHT information into EMRs for distant affected person monitoring, distant therapeutic monitoring, and power care administration, making a real-world information platform to watch the healthcare high quality of DHT and ML units in conventional and new client fashions of care supply.
Catherine Liao – Chief Technique Officer
Catherine Liao has served as our chief technique officer since September 2022. Beforehand, Liao served as chief govt officer of Blumio, a pioneering medical gadget startup, from February 2016 to September 2022, the place she led efforts in elevating capital, fashioned a management and advisory board wealthy in information spanning healthcare improvements, enterprise expertise, and sensor expertise. Her notable achievements embrace main the commercialization of a groundbreaking medical radar sensor improvement platform, which garnered important trade consideration and was finally acquired by Cardiex. Liao holds an MBA from Imperial Faculty London and a Grasp of Science in Well being Economics from the London College of Economics. These credentials underscore her deep and complete perception into the intricacies of each the enterprise world and the healthcare sector, demonstrating a balanced experience crucial for navigating and innovating inside as we speak’s complicated healthcare economies.
Mark Gorelick, Ph.D. – Chief Product Officer
Dr. Mark Gorelick has served as Cardiex’s chief product officer since December 2020, bringing a wealth of expertise from varied management roles within the well being and wellness expertise sector. With a formidable tenure starting in 2007, he has been on the helm as managing director of XPhys Applied sciences, an organization on the forefront of growing revolutionary health, well being, and wellness merchandise. His strategic imaginative and prescient was additional demonstrated by his function as vice-president of Digital Well being, from 2018 to 2019, at Efficiency Lab Applied sciences, acclaimed for its software program improvement prowess within the well being sector. Additional cementing his popularity in well being expertise, Gorelick served because the chief science officer at PAI Well being (initially Mio World) from 2015 to 2018, the place he was instrumental in advancing well being expertise software program options. Holding a BSc and MSc in kinesiology from Dalhousie College and a Ph.D. in biomedical science from College of Wollongong, Gorelick’s academic background underscores his deep-rooted understanding and revolutionary strategy to biomedical science and kinesiology, reinforcing his invaluable contribution to our firm and the broader well being expertise panorama.
This profile was written in collaboration with Couloir Capital.